Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balances (in shares) at Dec. 31, 2022 26,443,067        
Balances at Dec. 31, 2022   $ 128,078 $ (74) $ (96,177) $ 31,827
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 4,289        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense   422 0 0 422
Unrealized gain (loss) on marketable securities   0 45 0 45
Net loss   0 0 (5,272) $ (5,272)
Issuance of common shares in settlement of deferred stock units (in shares) 17,621       17,621
Net loss   0 0 (5,272) $ (5,272)
Balances (in shares) at Mar. 31, 2023 26,464,977        
Balances at Mar. 31, 2023   128,500 (29) (101,449) 27,022
Balances (in shares) at Dec. 31, 2023 37,958,000        
Balances at Dec. 31, 2023   166,609 6 (115,558) 51,057
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 5,916        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense   488     488
Unrealized gain (loss) on marketable securities     (45)   (45)
Net loss       (5,151) (5,151)
Net loss       (5,151) (5,151)
Balances (in shares) at Mar. 31, 2024 37,963,916        
Balances at Mar. 31, 2024   $ 167,097 $ (39) $ (120,709) $ 46,349